Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society …

PM Hawkey, RE Warren, DM Livermore… - Journal of …, 2018 - academic.oup.com
Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

Surgical antibiotic prophylaxis in an era of antibiotic resistance: common resistant bacteria and wider considerations for practice

BD Menz, E Charani, DL Gordon… - Infection and Drug …, 2021 - Taylor & Francis
The increasing incidence of antimicrobial resistance (AMR) presents a global crisis to
healthcare, with longstanding antimicrobial agents becoming less effective at treating and …

The surgical infection society revised guidelines on the management of intra-abdominal infection

JE Mazuski, JM Tessier, AK May, RG Sawyer… - Surgical …, 2017 - liebertpub.com
Background: Previous evidence-based guidelines on the management of intra-abdominal
infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and …

[PDF][PDF] Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study

J Fernández, J Acevedo, M Castro, O Garcia… - …, 2012 - Wiley Online Library
Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in
cirrhosis are poorly known. This work was a prospective evaluation in two series of cirrhotic …

Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study

M Sartelli, F Catena, L Ansaloni, F Coccolini… - World Journal of …, 2014 - Springer
The CIAOW study (Complicated intra-abdominal infections worldwide observational study) is
a multicenter observational study underwent in 68 medical institutions worldwide during a …

Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference

M Sartelli, F Catena, FM Abu-Zidan, L Ansaloni… - World journal of …, 2017 - Springer
This paper reports on the consensus conference on the management of intra-abdominal
infections (IAIs) which was held on July 23, 2016, in Dublin, Ireland, as a part of the annual …

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review

ME Falagas, AC Kastoris, AM Kapaskelis… - The Lancet infectious …, 2010 - thelancet.com
Rising rates of resistance to antimicrobial drugs among Enterobacteriaceae limit the choice
of reliably active forms of these drugs. We evaluated the evidence on fosfomycin as a …

Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States

Y Doi, YS Park, JI Rivera… - Clinical Infectious …, 2013 - academic.oup.com
Background. The occurrence of community-associated infections due to extended-spectrum
β-lactamase (ESBL)–producing Escherichia coli has been recognized as a major clinical …

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum β-lactamase–producing enterobacteriaceae, carbapenem …

SS Kanj, ZA Kanafani - Mayo Clinic Proceedings, 2011 - Elsevier
The development of antimicrobial resistance among gram-negative pathogens has been
progressive and relentless. Pathogens of particular concern include extended-spectrum β …

Public health risks of enterobacterial isolates producing extended-spectrum β-lactamases or AmpC β-lactamases in food and food-producing animals: an EU …

E Liebana, A Carattoli, TM Coque… - Clinical infectious …, 2013 - academic.oup.com
The bla ESBL and bla AmpC genes in Enterobacteriaceae are spread by plasmid-mediated
integrons, insertion sequences, and transposons, some of which are homologous in bacteria …